Investigational drug · Phase 2
PTX-100
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for CTCL.
Phase 2Last checked: Nov 19, 2026Latest source record: Sep 9, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
3
Any phase or sponsor naming "PTX-100"
First trial start
2025
Mar 28, 2025
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "PTX-100", any sponsor or status.
Conditions studied
As listed on its trial records.
- CTCL
Largest trials
Live from ClinicalTrials.gov: studies naming "PTX-100" as an intervention, largest first.
- Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi SarcomaPivotal-lookingNot yet recruiting
AIDS Malignancy ConsortiumResearch network
NCT05411237 · 130 participants (planned) · Start Sep 2026 · Primary completion Sep 2029
Drug: Pegylated liposomal doxorubicin; Paclitaxel · For: Kaposi Sarcoma; HIV-1-infection; AIDS-related Kaposi Sarcoma
- A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCLPivotal-lookingRecruiting
Prescient Therapeutics, Ltd.Industry
NCT06854653 · 115 participants (planned) · Start Mar 28, 2025 · Primary completion Jan 2028
Drug: PTX-100 · For: CTCL
Sites: Duarte, California; Irvine, California; New Haven, Connecticut · 15 sites in all
Prescient Therapeutics, Ltd.Industry
NCT03900442 · 25 participants · Start Sep 1, 2019 · Primary completion Jul 31, 2025
Drug: PTX-100 · For: Advanced Cancer; PTCL
Sites: Melbourne, Australia
Newest research
PubMed records naming it or its code names, newest first.
- Lithium prevents the neurotoxic effects of paclitaxel mediated through TRPA1 channels.
Sánchez JC, Valencia-Vásquez A, Olaya JC, et al. · Mol Pain 2026
- Geranylgeranyl transferase-1 inhibitor GGTI-2417 enhances the anti-tumour efficacy of histone deacetylase inhibitors in different T-cell lymphoma lines.
Hu X, Li L, Nkwocha J, et al. · Br J Haematol 2025
- [A Case of a Patient with Lung Adenocarcinoma on Hemodialysis Treated with Atezolizumab+Carboplatin+Nab-Paclitaxel].
Hanaka J, Kasuga M, Sakamoto Y, et al. · Gan To Kagaku Ryoho 2025
- Pentoxifylline protects memory performance in streptozotocin-induced diabetic rats.
Muhsen M, Alzoubi KH, Khabour OF, et al. · Brain Res 2025
- Therapeutic Potential of Pentoxifylline in Paraquat-Induced Pulmonary Toxicity: Role of the Phosphodiesterase Enzymes.
Ghasemi F, Mohammadi M, Ghaffari F, et al. · Drug Res (Stuttg) 2024
- Pentoxifylline as Add-On Treatment to Donepezil in Copper Sulphate-Induced Alzheimer's Disease-Like Neurodegeneration in Rats.
Elseweidy MM, Mahrous M, Ali SI, et al. · Neurotox Res 2023
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.